• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用全基因组测序对听力损失进行系统的遗传评估可识别出致病变异。

Systematic genetic assessment of hearing loss using whole-genome sequencing identifies pathogenic variants.

作者信息

Kim Jung Ah, Jang Seung Hyun, Joo Sun Yung, Kim Se Jin, Choi Jae Young, Jung Jinsei, Gee Heon Yung

机构信息

Department of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.

Won-Sang Lee Institute for Hearing Loss, Seoul, Republic of Korea.

出版信息

Exp Mol Med. 2025 Apr;57(4):775-787. doi: 10.1038/s12276-025-01428-x. Epub 2025 Apr 1.

DOI:10.1038/s12276-025-01428-x
PMID:40164689
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12046045/
Abstract

Hearing loss is a clinically and genetically heterogeneous sensorineural disease that affects approximately 1 out of 1000 newborns. For the molecular diagnosis of genetic hearing loss, target panel or whole-exome sequencing (WES) have been widely used due to their cost-effectiveness and efficacy. Despite the advantages of WES, the plausible diagnoses in a substantial number of patients remain elusive due to its limited coverage. Here we utilized whole-genome sequencing (WGS) on a large cohort of individuals with hearing loss to overcome the drawbacks of WES and find the advantages of WGS. We implemented a systematic workflow to identify coding region variants, cryptic splice variants, mitochondrial variants, copy number variants, cis-regulatory variants and transposable element insertions. WGS was conducted on 140 families with hearing loss. Causative variations were identified in 37 of these families, accounting for 26% of the total. WGS possessed the capability to find genetic variations that are not identifiable using WES. The identified variants by WGS in this study encompassed aberrant splicing variants in EYA1 and CDH23, mitochondrial variants in MT-RNR1 and MT-CO1, structural variants in STRC, and Alu insertion in SLC17A8. These findings highlight the benefits of WGS. With the decreasing cost of WGS, its usage will become more prevalent, allowing more precise identification of the genetic causes of hearing loss.

摘要

听力损失是一种临床和遗传异质性的感音神经性疾病,每1000名新生儿中约有1人受其影响。对于遗传性听力损失的分子诊断,靶向测序或全外显子组测序(WES)因其成本效益和有效性而被广泛应用。尽管WES有诸多优点,但由于其覆盖范围有限,大量患者的可能诊断仍难以确定。在此,我们对一大群听力损失个体进行了全基因组测序(WGS),以克服WES的缺点并发现WGS的优势。我们实施了一个系统流程来识别编码区变异、隐匿性剪接变异、线粒体变异、拷贝数变异、顺式调控变异和转座元件插入。对140个听力损失家庭进行了WGS。在其中37个家庭中鉴定出了致病变异,占总数的26%。WGS有能力发现使用WES无法识别的遗传变异。本研究中WGS鉴定出的变异包括EYA1和CDH23中的异常剪接变异、MT-RNR1和MT-CO1中的线粒体变异、STRC中的结构变异以及SLC17A8中的Alu插入。这些发现凸显了WGS的益处。随着WGS成本的降低,其应用将变得更加普遍,从而能够更精确地识别听力损失的遗传原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/c7398e8ebc5b/12276_2025_1428_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/a5ddde8af9d2/12276_2025_1428_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/5a49a2178f69/12276_2025_1428_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/6f3808c55cf2/12276_2025_1428_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/f5488a109eb3/12276_2025_1428_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/52d996328f99/12276_2025_1428_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/c7398e8ebc5b/12276_2025_1428_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/a5ddde8af9d2/12276_2025_1428_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/5a49a2178f69/12276_2025_1428_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/6f3808c55cf2/12276_2025_1428_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/f5488a109eb3/12276_2025_1428_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/52d996328f99/12276_2025_1428_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec0e/12046045/c7398e8ebc5b/12276_2025_1428_Fig6_HTML.jpg

相似文献

1
Systematic genetic assessment of hearing loss using whole-genome sequencing identifies pathogenic variants.使用全基因组测序对听力损失进行系统的遗传评估可识别出致病变异。
Exp Mol Med. 2025 Apr;57(4):775-787. doi: 10.1038/s12276-025-01428-x. Epub 2025 Apr 1.
2
Whole-genome sequencing, as a powerful diagnostic tool in hearing loss, reveals novel variants in PTPRQ missed by whole-exome sequencing.全基因组测序作为听力损失的一种强大诊断工具,揭示了全外显子组测序遗漏的PTPRQ基因中的新变异。
BMC Med Genomics. 2025 Mar 31;18(1):59. doi: 10.1186/s12920-025-02122-7.
3
Whole-exome sequencing identifies genetic variants of hearing loss in 113 Chinese families.全外显子组测序鉴定 113 个中国家系的耳聋基因突变。
Clin Chim Acta. 2022 Jul 1;532:53-60. doi: 10.1016/j.cca.2022.05.020. Epub 2022 May 28.
4
Identification of CDH23 mutations in Korean families with hearing loss by whole-exome sequencing.通过全外显子组测序鉴定韩国听力损失家系中的 CDH23 突变。
BMC Med Genet. 2014 Apr 28;15:46. doi: 10.1186/1471-2350-15-46.
5
Whole genome sequencing identifies elusive variants in genetically unsolved Italian inherited retinal disease patients.全基因组测序鉴定出遗传性视网膜疾病意大利未解决病例中的隐匿性变异。
HGG Adv. 2024 Jul 18;5(3):100314. doi: 10.1016/j.xhgg.2024.100314. Epub 2024 May 29.
6
Identification of novel CDH23 heterozygous variants causing autosomal recessive nonsyndromic hearing loss.导致常染色体隐性非综合征性听力损失的新型CDH23杂合变异体的鉴定。
Genes Genomics. 2025 Mar;47(3):293-305. doi: 10.1007/s13258-024-01611-w. Epub 2025 Jan 8.
7
Identification of copy number variants through whole-exome sequencing in autosomal recessive nonsyndromic hearing loss.通过全外显子组测序鉴定常染色体隐性非综合征性听力损失中的拷贝数变异
Genet Test Mol Biomarkers. 2014 Sep;18(9):658-61. doi: 10.1089/gtmb.2014.0121. Epub 2014 Jul 25.
8
Novel genetic determinants contribute to hearing loss in a central European cohort with enlarged vestibular aqueduct.新的遗传决定因素导致中欧大前庭导水管队列中的听力损失。
Mol Med. 2025 Mar 22;31(1):111. doi: 10.1186/s10020-025-01159-9.
9
Limited Added Diagnostic Value of Whole Genome Sequencing in Genetic Testing of Inherited Retinal Diseases in a Swiss Patient Cohort.全基因组测序在瑞士遗传视网膜疾病患者队列中的附加诊断价值有限。
Int J Mol Sci. 2024 Jun 13;25(12):6540. doi: 10.3390/ijms25126540.
10
A novel copy number variant in the murine Cdh23 gene gives rise to profound deafness and vestibular dysfunction.一种新型的 Cdh23 基因拷贝数变异导致严重的耳聋和前庭功能障碍。
Hum Mol Genet. 2024 Sep 19;33(19):1648-1659. doi: 10.1093/hmg/ddae095.

引用本文的文献

1
The audiological phenotype of patients with a variant in MYH9 and MYH14 genes.MYH9和MYH14基因变异患者的听力学表型。
Sci Rep. 2025 Jul 1;15(1):22324. doi: 10.1038/s41598-025-08801-w.

本文引用的文献

1
Genome Sequencing for Diagnosing Rare Diseases.基因组测序在罕见病诊断中的应用。
N Engl J Med. 2024 Jun 6;390(21):1985-1997. doi: 10.1056/NEJMoa2314761.
2
Brief guide to RNA sequencing analysis for nonexperts in bioinformatics.非生物信息学专业人士的 RNA 测序分析简介
Mol Cells. 2024 May;47(5):100060. doi: 10.1016/j.mocell.2024.100060. Epub 2024 Apr 16.
3
Prevalence and Clinical Characteristics of Mitochondrial DNA Mutations in Korean Patients With Sensorineural Hearing Loss.韩国感音神经性听力损失患者中线粒体 DNA 突变的流行情况和临床特征。
J Korean Med Sci. 2023 Dec 11;38(48):e355. doi: 10.3346/jkms.2023.38.e355.
4
Contribution and therapeutic implications of retroelement insertions in ataxia telangiectasia.反转录元件插入在共济失调毛细血管扩张症中的作用和治疗意义。
Am J Hum Genet. 2023 Nov 2;110(11):1976-1982. doi: 10.1016/j.ajhg.2023.09.008. Epub 2023 Oct 5.
5
Novel Variant in Causes Protein Mislocalization and Leads to Nonsyndromic Autosomal Recessive Type of Progressive Hearing Loss.某基因中的新型变异导致蛋白质定位错误并引发非综合征性常染色体隐性进行性听力损失。
Cells. 2023 Sep 21;12(18):2328. doi: 10.3390/cells12182328.
6
Beyond the exome: What's next in diagnostic testing for Mendelian conditions.外显子组之外:孟德尔疾病诊断检测的下一步是什么。
Am J Hum Genet. 2023 Aug 3;110(8):1229-1248. doi: 10.1016/j.ajhg.2023.06.009.
7
Congenital Cytomegalovirus and Hearing Loss: The State of the Art.先天性巨细胞病毒与听力损失:最新进展
J Clin Med. 2023 Jul 3;12(13):4465. doi: 10.3390/jcm12134465.
8
A framework for individualized splice-switching oligonucleotide therapy.个体化剪接寡核苷酸治疗的框架。
Nature. 2023 Jul;619(7971):828-836. doi: 10.1038/s41586-023-06277-0. Epub 2023 Jul 12.
9
ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).ACMG SF v3.2 临床外显子组和基因组测序中报告次要发现的列表:美国医学遗传学与基因组学学会 (ACMG) 的政策声明。
Genet Med. 2023 Aug;25(8):100866. doi: 10.1016/j.gim.2023.100866. Epub 2023 Jun 22.
10
Genome sequencing identifies coding and non-coding variants for non-syndromic hearing loss.基因组测序鉴定出非综合征性听力损失的编码和非编码变异。
J Hum Genet. 2023 Oct;68(10):657-669. doi: 10.1038/s10038-023-01159-9. Epub 2023 May 22.